{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:32:34Z","timestamp":1785403954540,"version":"3.56.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.rdc.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T20:34:57Z","timestamp":1458160497000},"page":"301-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Patient-Reported Outcome Measures in Systemic Sclerosis (Scleroderma)"],"prefix":"10.1016","volume":"42","author":[{"given":"Russell E.","family":"Pellar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Tingey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet Elizabeth","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rdc.2016.01.003_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3899\/jrheum.100635","article-title":"Disability in systemic sclerosis - a longitudinal observational study","volume":"38","author":"Schnitzer","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.003_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jbspin.2008.07.003","article-title":"Systemic sclerosis: an update in 2008","volume":"75","author":"Allanore","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.003_bib4","first-page":"1117","article-title":"Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases","volume":"33","author":"Johnson","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib5","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib6","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"Leroy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib7","series-title":"Textbook of rheumatology","first-page":"1133","article-title":"Connective tissue diseases characterized by fibrosis","author":"Seibold","year":"2001"},{"key":"10.1016\/j.rdc.2016.01.003_bib8","series-title":"Primer on the rheumatic diseases","first-page":"357","article-title":"Clinical features","author":"Wigley","year":"2001"},{"key":"10.1016\/j.rdc.2016.01.003_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","article-title":"Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being","volume":"29","author":"Medsger","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2016.01.003_bib10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1346-8138.2003.tb00413.x","article-title":"Cutaneous concerns of scleroderma patients","volume":"30","author":"Paquette","year":"2003","journal-title":"J\u00a0Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.003_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/keg145","article-title":"A\u00a0cross-sectional comparison of\u00a0three self-reported functional indices in scleroderma","volume":"42","author":"Smyth","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2016.01.003_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1874312900802010044","article-title":"Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores","volume":"2","author":"Ouimet","year":"2008","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.rdc.2016.01.003_bib13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3899\/jrheum.080281","article-title":"Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions","volume":"36","author":"Hudson","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.003_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3899\/jrheum.090375","article-title":"The minimally important difference (MID) for patient centered outcomes including Health Assessment Questionnaire (HAQ), Fatigue, Pain, Sleep, Global VAS and SF-36 in Scleroderma (SSc)","volume":"37","author":"Sekhon","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib15","series-title":"Scleroderma: from pathogenesis to comprehensive management","year":"2012"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.003_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.20108","article-title":"Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis","volume":"62","author":"Schieir","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.003_bib17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/acr.20257","article-title":"Association of pruritus with quality of life and disability in systemic sclerosis","volume":"62","author":"El-Baalbaki","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2016.01.003_bib18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0190-9622(03)02478-2","article-title":"Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease","volume":"49","author":"Zucker","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","article-title":"Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey","volume":"50","author":"Bassel","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.003_bib20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/art.23524","article-title":"Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis","volume":"59","author":"Thombs","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.003_bib21","doi-asserted-by":"crossref","first-page":"e33281","DOI":"10.1371\/journal.pone.0033281","article-title":"Sociodemographic and disease correlates of body image distress among patients with systemic sclerosis","volume":"7","author":"Jewett","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.003_bib22","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/rheumatology\/kep240","article-title":"(Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples","volume":"48","author":"Knafo","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.rdc.2016.01.003_bib23","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3899\/jrheum.081237","article-title":"Work disability in systemic sclerosis","volume":"36","author":"Hudson","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.bor.0000434666.47397.c2","article-title":"Psychosocial aspects of systemic sclerosis","volume":"25","author":"Malcarne","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib25","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/acr.20187","article-title":"Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda","volume":"62","author":"Thombs","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"S11","key":"10.1016\/j.rdc.2016.01.003_bib26","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/acr.20598","article-title":"Measures of systemic sclerosis (Scleroderma)","volume":"63","author":"Pope","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2016.01.003_bib27","first-page":"171826","article-title":"Disease and symptom burden in systemic sclerosis: a patient perspective","volume":"34","author":"Suarez-Almazor","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/art.21084","article-title":"The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties","volume":"53","author":"Johnson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib30","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","article-title":"Measuring disease activity and functional status in patients with scleroderma and Raynaud\u2019s phenomenon","volume":"46","author":"Merkel","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.003_bib31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/1529-0131(200103)44:3<653::AID-ANR114>3.0.CO;2-Q","article-title":"The disability index of the health assessment questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial","volume":"44","author":"Clements","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2016.01.003_bib32","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.1780401110","article-title":"The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib33","first-page":"466","article-title":"Does incorporation of aids and devices make a difference in the score of the health assessment questionnaire-disability index? Analysis from a scleroderma clinical trial","volume":"35","author":"Khanna","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib34","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3899\/jrheum.100354","article-title":"Discordance between patient and physician assessments of disease severity in systemic sclerosis","volume":"37","author":"Hudson","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib35","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/rheumatology\/keh070","article-title":"The Health Assessment Questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma","volume":"43","author":"Sultan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2016.01.003_bib37","first-page":"832","article-title":"Responsiveness of the SF-36 and the Health Assessment Questionnaire disability index in a systemic sclerosis clinical trial","volume":"32","author":"Khanna","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol-a new facility for the measurement of health-related quality of life","volume":"16","author":"The EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.rdc.2016.01.003_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.003_bib40","first-page":"210","article-title":"Health related quality of life assessment in patients with systemic sclerosis","volume":"62","author":"Gualtierotti","year":"2010","journal-title":"Reumatismo"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.003_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2133.2011.10624.x","article-title":"Determinants of disability, quality of life\u00a0and depression in dermatological patients with systemic scleroderma","volume":"166","author":"Muller","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib42","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10067-012-1997-1","article-title":"Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools","volume":"31","author":"Strickland","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"2 Suppl 76","key":"10.1016\/j.rdc.2016.01.003_bib43","first-page":"50","article-title":"A\u00a0comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis","volume":"31","author":"Kwakkenbos","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short health survey (SF-36) I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.003_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical validity in measuring physical and mental health constructs","volume":"31","author":"McHorney","year":"1993","journal-title":"Med Care"},{"key":"10.1016\/j.rdc.2016.01.003_bib46","series-title":"Scleroderma: from pathogenesis to comprehensive management","first-page":"661","article-title":"Measuring disease activity and outcomes in clinical trials","author":"Khanna","year":"2012"},{"key":"10.1016\/j.rdc.2016.01.003_bib47","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3899\/jrheum.090504","article-title":"The symptom burden index: development and initial findings from use with patients with systemic sclerosis","volume":"37","author":"Kallen","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.003_bib48","first-page":"79","article-title":"Assessment of functional ability in patients with scleroderma: a proposed disability assessment instrument","volume":"25","author":"Silman","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib49","first-page":"1167","article-title":"Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap","volume":"23","author":"Duruoz","year":"1996","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib50","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.20701","article-title":"Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma)","volume":"51","author":"Brower","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/art.22468","article-title":"Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey","volume":"57","author":"Rannou","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib52","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1053\/joca.2001.0422","article-title":"Reliability, validity, and sensitivity to change of the Cochin Hand Functional Disability Scale in hand osteoarthritis","volume":"9","author":"Poiraudeau","year":"2001","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.rdc.2016.01.003_bib53","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/rheumatology\/40.8.843","article-title":"Responsiveness of the Cochin rheumatoid disability scale after surgery","volume":"40","author":"Lefevre-Colau","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2016.01.003_bib54","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/1529-0131(200010)13:5<296::AID-ANR9>3.0.CO;2-F","article-title":"The ability of the Cochin Rheumatoid Arthritis Hand Functional Scale to detect change during the course of disease","volume":"13","author":"Poiraudeau","year":"2000","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2016.01.003_bib55","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1002\/acr.20631","article-title":"Measures of hand function","volume":"63","author":"Poole","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2016.01.003_bib56","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0003-9993(98)90167-8","article-title":"ABILHAND: a Rasch-built measure of manual ability","volume":"79","author":"Penta","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.003_bib57","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/art.24426","article-title":"Validation of a manual ability questionnaire in patients with systemic sclerosis","volume":"61","author":"Vanthuyne","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L","article-title":"Development of an upper extremity outcome measure: the DASH (Disabilities of the Arm, Shoulder and Hand)","volume":"29","author":"Hudak","year":"1996","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.rdc.2016.01.003_bib59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1471-2474-10-161","article-title":"A\u00a0modified QuickDASH-9 provides a valid outcome instrument for upper limb function","volume":"10","author":"Gabel","year":"2009","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.003_bib60","first-page":"776","article-title":"Cross-cultural adaptation of the disabilities of the arm, shoulder, and hand (DASH) questionnaire into Hungarian and investigation of its validity in patients with systemic sclerosis","volume":"26","author":"Varju","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0363-5023(98)80042-7","article-title":"Reliability and validity testing of the Michigan hand outcomes questionnaire","volume":"23","author":"Chung","year":"1998","journal-title":"J\u00a0Hand Surg Am"},{"key":"10.1016\/j.rdc.2016.01.003_bib62","series-title":"Validation of the Michigan Hand Outcomes Questionnaire (MHQ) in Systemic Sclerosis (SSc)","author":"Impens","year":"2004"},{"key":"10.1016\/j.rdc.2016.01.003_bib63","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1136\/ard.2007.070532","article-title":"Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale","volume":"66","author":"Mouthon","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2016.01.003_bib64","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.1780370902","article-title":"Gastrointestinal motility disorders in scleroderma","volume":"37","author":"Sjogren","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib65","first-page":"763","article-title":"Gastrointestinal manifestations of progressive systemic sclerosis","volume":"92","author":"Lock","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rdc.2016.01.003_bib66","first-page":"51","article-title":"Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis","volume":"32","author":"Nietert","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib67","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/art.21999","article-title":"Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis","volume":"55","author":"Gliddon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib68","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/art.22987","article-title":"Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument","volume":"57","author":"Khanna","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib69","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.24730","article-title":"Reliability and validity of the University of California, Los Angeles Scleroderma clinical trial consortium gastrointestinal tract instrument","volume":"61","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2016.01.003_bib70","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3899\/jrheum.110060","article-title":"Validation of the UCLA Scleroderma Clinical Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosis","volume":"38","author":"Baron","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"2 Suppl 65","key":"10.1016\/j.rdc.2016.01.003_bib71","first-page":"S22","article-title":"Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating\/distention","volume":"29","author":"Frech","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib72","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/bjs.1800820229","article-title":"Gastrointestinal Quality of Life Index: development, validation and application of a new instrument","volume":"82","author":"Eypasch","year":"1995","journal-title":"Br J Surg"},{"key":"10.1016\/j.rdc.2016.01.003_bib73","first-page":"359","article-title":"Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis","volume":"34","author":"Malcarne","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib74","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1037\/0278-6133.22.2.130","article-title":"Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function","volume":"22","author":"Benrud-Larson","year":"2003","journal-title":"Health Psychol"},{"key":"10.1016\/j.rdc.2016.01.003_bib75","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8","article-title":"Calcium channel blockers for Raynaud\u2019s phenomenon in progressive systemic sclerosis","volume":"44","author":"Thompson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib76","first-page":"1603","article-title":"Retest reliabilities and variability among scleroderma patients for 4 tests of disability: support for a better measure. Presented at the Canadian Rheumatology Association Meeting, 1995","volume":"22","author":"Stevens","year":"1995","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib77","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/ard.2009.107706","article-title":"The minimally important difference and patient acceptable symptom state for the Raynaud\u2019s condition score in patients with Raynaud\u2019s phenomenon in a large randomised controlled clinical trial","volume":"69","author":"Khanna","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2016.01.003_bib78","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/rheumatology\/keq291","article-title":"Efficacy of tadalafil in secondary Raynaud\u2019s phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial","volume":"49","author":"Shenoy","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 5","key":"10.1016\/j.rdc.2016.01.003_bib79","doi-asserted-by":"crossref","first-page":"v46","DOI":"10.1093\/rheumatology\/ken310","article-title":"Digital ulcers and outcomes assessment in scleroderma","volume":"47","author":"Matucci-Cerinic","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2016.01.003_bib80","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1378\/chest.85.6.751","article-title":"The measurement of dyspnea: contents, interobserver agreement and physiologic correlates of two new clinical indexes","volume":"85","author":"Mahler","year":"1984","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2016.01.003_bib81","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2016.01.003_bib82","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/art.20787","article-title":"Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study","volume":"52","author":"Khanna","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib83","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/art.22580","article-title":"Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study","volume":"56","author":"Khanna","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.01.003_bib84","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical basis of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.rdc.2016.01.003_bib85","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11136-005-3513-4","article-title":"The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension","volume":"15","author":"McKenna","year":"2006","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.003_bib86","first-page":"508","article-title":"Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis","volume":"31","author":"Hong","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.003_bib87","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","article-title":"The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years","volume":"45","author":"Cella","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.rdc.2016.01.003_bib88","series-title":"Scleroderma: from pathogenesis to comprehensive management","first-page":"673","article-title":"Patient-reported outcomes","author":"Hinchcliff","year":"2012"},{"key":"10.1016\/j.rdc.2016.01.003_bib89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.rdc.2016.01.003_bib90","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jval.2011.08.006","article-title":"Feasibility and Construct Validity of PROMIS and \u201cLegacy\u201d Instruments in an Academic Scleroderma Clinic","volume":"15","author":"Khanna","year":"2012","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.rdc.2016.01.003_bib91","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/acr.20591","article-title":"Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form","volume":"63","author":"Hinchcliff","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.003_bib92","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3899\/jrheum.140143","article-title":"Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis","volume":"42","author":"Hinchcliff","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.003_bib93","first-page":"122","article-title":"Evaluation of quality of life in patients with systemic sclerosis by the SR-36 questionnaire","volume":"54","author":"Cosutta","year":"2002","journal-title":"Rheumatismo"},{"key":"10.1016\/j.rdc.2016.01.003_bib94","first-page":"402","article-title":"Validity of the scleroderma functional assessment questionnaire","volume":"31","author":"Poole","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2016.01.003_bib95","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/rheumatology\/kel432","article-title":"Using a self-reported functional score to assess disease progression in systemic sclerosis","volume":"46","author":"Serednicka","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.003_bib96","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/rheumatology\/kes206","article-title":"Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy \u2013 Fatigue Scale","volume":"51","author":"Harel","year":"2012","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16000041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16000041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:38Z","timestamp":1760181218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X16000041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0889857X16000041"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2016.01.003","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Reported Outcome Measures in Systemic Sclerosis (Scleroderma)","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}